We are live on
!
Find out more
NCM
Niemann Capital Management Portfolio holdings
AUM
$788K
1-Year Est. Return
23.27%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+23.27%
3 Year Est. Return
+102.79%
5 Year Est. Return
+328.66%
10 Year Est. Return
–
AUM
$146M
AUM Growth
-$611K
(-0.42%)
Cap. Flow
-$8.64M
Cap. Flow
% of AUM
-5.9%
Top 10 Holdings %
Top 10 Hldgs %
77.61%
Holding
36
New
16
Increased
2
Reduced
3
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$14.6M |
| 2 |
First Trust Utilities AlphaDEX Fund
FXU
|
+$14.2M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$13.4M |
| 4 |
Invesco S&P 500 Equal Weight Utilities ETF
RSPU
|
+$11.1M |
| 5 |
VanEck Pharmaceutical ETF
PPH
|
+$7.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Biotech ETF
BBH
|
+$14.4M |
| 2 |
iShares US Healthcare ETF
IYH
|
+$11.4M |
| 3 |
XLVS
POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO
XLVS
|
+$10.8M |
| 4 |
Invesco S&P Spin-Off ETF
CSD
|
+$9.71M |
| 5 |
WisdomTree Europe SmallCap Dividend Fund
DFE
|
+$7.73M |
Sector Composition
| Rank | Sector | Weight |
|---|
Similar funds
RC
GBA
AIDCT
VAIA
SAM
FPC
GFWEX
HAM
Niemann Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Niemann Capital Management held 36 positions worth $146M, down 0.42% from $147M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Niemann Capital Management withdrew a net $8.64M in Q2 2014, closing 15 positions and reducing 3 holdings. Its most notable exit was VanEck Biotech ETF, an estimated $14.4M position sold in full.
Against the trend, Niemann Capital Management opened a new position in First Trust Consumer Staples AlphaDEX Fund worth $15.3M.
- Niemann Capital Management's largest Q2 2014 buy was First Trust Consumer Staples AlphaDEX Fund: 384,359 shares worth $15.3M.
- Niemann Capital Management added most to First Trust Global Wind Energy ETF in Q2 2014, an estimated $40.6K increase.
- Niemann Capital Management's biggest Q2 2014 reduction was iShares Biotechnology ETF, cutting an estimated $5.98M.
- Niemann Capital Management fully exited VanEck Biotech ETF in Q2 2014, selling an estimated $14.4M.
- Niemann Capital Management's ten largest holdings make up 78% of its $146M portfolio in Q2 2014.
- Niemann Capital Management opened 16 new positions and closed 15 in Q2 2014.
- Niemann Capital Management's portfolio value fell 0.42% quarter-over-quarter to $146M.
Based on Niemann Capital Management's 13F filing for Q2 2014, filed 4 Aug 2014.